Ignite Creation Date:
2024-05-06 @ 1:31 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01828112
Status:
COMPLETED
Last Update Posted:
2023-11-30
First Post:
2013-04-02
Brief Title:
LDK378 Versus Chemotherapy in ALK Rearranged ALK Positive Patients Previously Treated With Chemotherapy Platinum Doublet and Crizotinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-02
First Submit QC Date:
April 9 2013
Study First Post Date:
2013-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-07-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-27
Last Update Post Date:
2023-11-30
Last Update Post Date Type:
ACTUAL